Aminophyllin and Post procedural complication - a phase IV clinical study of FDA data

Summary:

Post procedural complication is reported as a side effect among people who take Aminophyllin (aminophylline), especially for people who are male, 60+ old, also take Spironolactone, and have Asthma.

The phase IV clinical study analyzes which people have Post procedural complication when taking Aminophyllin. It is created by eHealthMe based on reports of 3,088 people who have side effects when taking Aminophyllin from the FDA, and is updated regularly.

What is Aminophyllin?

Aminophyllin has active ingredients of aminophylline. eHealthMe is studying from 3,118 Aminophyllin users. Check the latest studies of Aminophyllin.

What is Post procedural complication?

Post procedural complication is found to be associated with 1,089 drugs and 1,362 conditions by eHealthMe. Check the latest studies of Post procedural complication.



On Jul, 13, 2026

3,088 people reported to have side effects when taking Aminophyllin.
Among them, 11 people (0.36%) have Post procedural complication.

Could Aminophyllin cause Post procedural complication?

Among these 11 people:

What is the gender of people who have Post procedural complication when taking Aminophyllin? *

  • female: 40 %
  • male: 60 %

What is the age of people who have Post procedural complication when taking Aminophyllin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 9.09 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 27.27 %
  • 50-59: 9.09 %
  • 60+: 54.55 %

What are other drugs people take besides Aminophyllin? *

  1. Furosemide: 6 people, 54.55%
  2. Aspirin: 6 people, 54.55%
  3. Spironolactone: 6 people, 54.55%
  4. Morphine: 4 people, 36.36%
  5. Xolair: 3 people, 27.27%
  6. Atrovent: 3 people, 27.27%
  7. Isosorbide Mononitrate: 3 people, 27.27%
  8. Diovan: 3 people, 27.27%
  9. Carvedilol: 3 people, 27.27%
  10. Ramipril: 3 people, 27.27%

What are other side effects people have besides Post procedural complication? *

  1. Haemorrhage (bleeding): 5 people, 45.45%
  2. Post Procedural Haemorrhage (post procedural bleeding): 4 people, 36.36%
  3. Hypotension (abnormally low blood pressure): 4 people, 36.36%
  4. High Blood Pressure: 4 people, 36.36%
  5. Weakness: 4 people, 36.36%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 36.36%
  7. Weight Decreased: 3 people, 27.27%
  8. Injection Site Discomfort: 3 people, 27.27%
  9. Heavy Or Prolong Menstrual Bleeding: 3 people, 27.27%
  10. Haematemesis (vomiting of blood): 3 people, 27.27%

What are the existing conditions these people have? *

  1. Asthma: 4 people, 36.36%
  2. Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Aminophyllin and have Post procedural complication?

- Check whether Post procedural complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aminophyllin:

Post procedural complication treatments and more:

How severe was Post procedural complication and when was it recovered:

Expand to all the drugs that have ingredients of aminophylline:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aminophyllin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural complication:

Browse all the conditions that are associated with Post procedural complication:


How the study uses the data?

The study uses data from the FDA. It is based on aminophylline (the active ingredients of Aminophyllin) and Aminophyllin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: